HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High IgE levels to α-lactalbumin, β-lactoglobulin and casein predict less successful cow's milk oral immunotherapy.

AbstractBACKGROUND:
A new treatment option for persistent cow's milk allergy (CMA) is oral immunotherapy (OIT). Not all patients develop tolerance during therapy, and markers to identify those who will benefit from it are needed. The objective was to study the IgE and IgG4 antibody profiles to milk and milk proteins before and after OIT in relation to clinical outcome.
METHODS:
Seventy-six children (5-17 years) with challenge-verified CMA were subjected to a 6-month OIT protocol. The treatment aimed at reaching a maintenance dose of 200 ml CM (high dose = HD). Those who did not reach target were analysed as a low-dose (LD) group. Sera were characterized before and after OIT regarding serum levels of IgE and IgG4 to milk and five milk allergen components evaluated together with clinical CMA symptoms and outcome of OIT.
RESULTS:
Fifty-five (72%) patients reached the maintenance dose (HD) during therapy. High specific IgE levels towards the milk allergens α-lactalbumin (P = 0.048), β-lactoglobulin (P = 0.006) and casein (P = 0.015) before OIT start were associated with lower maintenance dose reached. Patients who developed desensitization had a larger increase in IgG4 levels to α-lactalbumin (P = 0.034), β-lactoglobulin (P = 0.010), casein (P = 0.047) and lactoferrin (P = 0.030) during treatment than those who failed.
CONCLUSIONS:
Component-resolved diagnostics before OIT can help to identify children with lower probability of a successful OIT outcome, as high IgE levels to α-lactalbumin, β-lactoglobulin and casein are associated with lower maintenance dose reached. An increase in the IgG4 concentration to milk components during treatment indicated effective desensitization.
AuthorsM Kuitunen, H Englund, S Remes, R Movérare, A Pelkonen, M P Borres, M J Mäkelä
JournalAllergy (Allergy) Vol. 70 Issue 8 Pg. 955-62 (Aug 2015) ISSN: 1398-9995 [Electronic] Denmark
PMID25951431 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • Biomarkers
  • Caseins
  • Immunoglobulin E
  • Lactalbumin
Topics
  • Administration, Oral
  • Adolescent
  • Animals
  • Biomarkers (blood)
  • Caseins (blood, immunology)
  • Cattle
  • Child
  • Child, Preschool
  • Cohort Studies
  • Desensitization, Immunologic (methods)
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin E (blood)
  • Immunotherapy (methods)
  • Lactalbumin (blood, immunology)
  • Male
  • Milk (adverse effects, immunology)
  • Milk Hypersensitivity (blood, diagnosis, therapy)
  • Predictive Value of Tests
  • Prospective Studies
  • Risk Assessment
  • Statistics, Nonparametric
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: